Reporting of preclinical tumor-graft cancer therapeutic studies

Por Sugar, Elizabeth, Pascoe, Adam J., Azad, Nilofer
Publicado em 2012

Racial Disparities and Colorectal Cancer Survival in Older Adults With and Without Diabetes Mellitus

Por Waheed, Salman, Azad, Nilofer, Waheed, Sehrish, Yeh, Hsin-Chieh
Publicado no J Gastroenterol Hepatol (2014)

A thymidylate synthase ternary complex-specific antibody, FTS, permits functional monitoring of fluoropyrimidines dosing

Por Patel, Kalpesh, Yerram, Sashidhar R., Azad, Nilofer A., Kern, Scott E.
Publicado em 2012

The future of epigenetic therapy in solid tumours—lessons from the past

Por Azad, Nilofer, Zahnow, Cynthia A., Rudin, Charles M., Baylin, Stephen B.
Publicado em 2013

Proteomics as a Tool for Biomarker Discovery

Por Kohn, Elise C., Azad, Nilofer, Annunziata, Christina, Dhamoon, Amit S., Whiteley, Gordon
Publicado em 2007

A robust and rapid liquid chromatography tandem mass spectrometric method for the quantitative analysis of 5-azacytidine

Por Anders, Nicole M., Wanjiku, Teresia M., He, Ping, Azad, Nilofer S., Rudek, Michelle A.
Publicado no Biomed Chromatogr (2015)

Keratoacanthomas associated with sorafenib therapy

Por Kong, Heidi H., Cowen, Edward W., Azad, Nilofer S., Dahut, William, Gutierrez, Martin, Turner, Maria L.
Publicado em 2007

CHFR silencing or microsatellite instability is associated with increased anti-tumor activity of docetaxel or gemcitabine in colorectal cancer

Por Pelosof, Lorraine, Yerram, Sashidhar R, Ahuja, Nita, Delmas, Andrew, Danilova, Ludmila, Herman, James G., Azad, Nilofer S
Publicado em 2013

Mutational profiling of colorectal cancers with microsatellite instability

Por Lin, Elaine I., Tseng, Li-Hui, Gocke, Christopher D., Reil, Stacy, Le, Dung T., Azad, Nilofer S., Eshleman, James R.
Publicado no Oncotarget (2015)

Combined Inhibition of Cyclin-Dependent Kinases (Dinaciclib) and AKT (MK-2206) Blocks Pancreatic Tumor Growth and Metastases in Patient-Derived Xenograft Models

Por Hu, Chaoxin, Dadon, Tikva, Chenna, Venugopal, Yabuuchi, Shinichi, Bannerji, Rajat, Booher, Robert, Strack, Peter, Azad, Nilofer, Nelkin, Barry D., Maitra, Anirban
Publicado no Mol Cancer Ther (2015)

A randomized pilot trial of a telephone-based couples intervention for physical intimacy and sexual concerns in colorectal cancer

Por Reese, Jennifer Barsky, Porter, Laura S., Regan, Katelyn R., Keefe, Francis J., Azad, Nilofer S., Diaz, Luis A., Herman, Joseph M., Haythomthwaite, Jennifer A.
Publicado no Psychooncology (2014)

DNA-intercalators Causing Rapid Re-expression of Methylated and Silenced Genes in Cancer Cells

Por Hossain, M. Zulfiquer, Healey, Megan A., Lee, Calvin, Poh, Weijie, Yerram, Sashidhar R., Patel, Kalpesh, Azad, Nilofer S., Herman, James G., Kern, Scott E.
Publicado em 2013

Single-Center Phase II Trial of Transarterial Chemoembolization With Drug-Eluting Beads for Patients With Unresectable Hepatocellular Carcinoma: Initial Experience in the United St...

Por Reyes, Diane K., Vossen, Josephina A., Kamel, Ihab R., Azad, Nilofer S., Wahlin, Tamara A., Torbenson, Michael S., Choti, Michael A., Geschwind, Jean-Francois H.
Publicado no Cancer J (2009)

Performance characteristics of next-generation sequencing in clinical mutation detection of colorectal cancers

Por Haley, Lisa, Tseng, Li-Hui, Zheng, Gang, Dudley, Jonathan, Anderson, Derek A, Azad, Nilofer S, Gocke, Christopher D, Eshleman, James R, Lin, Ming-Tseh
Publicado no Mod Pathol (2015)

A Phase 1 dose escalation study of NEO-102 in patients with refractory colon and pancreatic cancer

Por Beg, Muhammad S., Azad, Nilofer S., Patel, Sandip P., Torrealba, Jose, Mavroukakis, Sharon, Beatson, Melony A., Wang, Xue Ping, Arlen, Philip M., Morse, Michael A.
Publicado no Cancer Chemother Pharmacol (2016)

Incidence and Prognostic Impact of KRAS and BRAF Mutation in Patients Undergoing Liver Surgery for Colorectal Metastases

Por Karagkounis, Georgios, Torbenson, Michael S., Daniel, Hubert D., Azad, Nilofer S., Diaz, Luis A., Donehower, Ross C., Hirose, Kenzo, Ahuja, Nita, Pawlik, Timothy M., Choti, Michael A.
Publicado em 2013

A Phase I study of paclitaxel and continuous daily CAI in patients with refractory solid tumors

Por Azad, Nilofer, Perroy, Alyssa, Gardner, Erin, Imamura, Chiyo K., Graves, Cynthia, Sarosy, Gisele A., Minasian, Lori, Kotz, Herbert, Raggio, Miranda, Figg, William D., Kohn, Elise C.
Publicado em 2009

HAND-FOOT SKIN REACTION INCREASES WITH CUMULATIVE SORAFENIB DOSE AND WITH COMBINATION ANTI-VEGF THERAPY

Por Azad, Nilofer S., Aragon-Ching, Jeanny B., Dahut, William L., Gutierrez, Martin, Figg, William D., Jain, Lokesh, Steinberg, Seth M., Turner, Maria L., Kohn, Elise C., Kong, Heidi H.
Publicado em 2009

Correction: A new immunohistochemistry prognostic score (IPS) for recurrence and survival in resected pancreatic neuroendocrine tumors (PanNET)

Por Viúdez, Antonio, Carvalho, Filipe L.F., Maleki, Zahra, Zahurak, Marianna, Laheru, Daniel, Stark, Alejandro, Azad, Nilofer S., Wolfgang, Christopher L., Baylin, Stephen, Herman, James G., De Jesus-Acosta, Ana
Publicado no Oncotarget (2017)

Emerging evidence for CHFR as a cancer biomarker: from tumor biology to precision medicine

Por Derks, Sarah, Cleven, Arjen H. G., Melotte, Veerle, Smits, Kim M., Brandes, Johann C., Azad, Nilofer, van Criekinge, Wim, de Bruïne, Adriaan P., Herman, James G., van Engeland, Manon
Publicado em 2013